These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1670 related articles for article (PubMed ID: 15308767)

  • 1. Bacterial persistence as a phenotypic switch.
    Balaban NQ; Merrin J; Chait R; Kowalik L; Leibler S
    Science; 2004 Sep; 305(5690):1622-5. PubMed ID: 15308767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic resistant single-cell characteristics under recurring ampicillin antibiotic exposure in
    Kollerová S; Jouvet L; Smelková J; Zunk-Parras S; Rodríguez-Rojas A; Steiner UK
    mSystems; 2024 Jul; 9(7):e0025624. PubMed ID: 38920373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiology. Noninherited resistance to antibiotics.
    Levin BR
    Science; 2004 Sep; 305(5690):1578-9. PubMed ID: 15361616
    [No Abstract]   [Full Text] [Related]  

  • 4. PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli.
    Li Y; Zhang Y
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2092-9. PubMed ID: 17420206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of phenotypic inheritance associated with
    Hingley-Wilson SM; Ma N; Hu Y; Casey R; Bramming A; Curry RJ; Tang HL; Wu H; Butler RE; Jacobs WR; Rocco A; McFadden J
    Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4152-4157. PubMed ID: 32029596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reassessing the Role of Type II Toxin-Antitoxin Systems in Formation of Escherichia coli Type II Persister Cells.
    Goormaghtigh F; Fraikin N; Putrinš M; Hallaert T; Hauryliuk V; Garcia-Pino A; Sjödin A; Kasvandik S; Udekwu K; Tenson T; Kaldalu N; Van Melderen L
    mBio; 2018 Jun; 9(3):. PubMed ID: 29895634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persister Escherichia coli Cells Have a Lower Intracellular pH than Susceptible Cells but Maintain Their pH in Response to Antibiotic Treatment.
    Goode O; Smith A; Zarkan A; Cama J; Invergo BM; Belgami D; Caño-Muñiz S; Metz J; O'Neill P; Jeffries A; Norville IH; David J; Summers D; Pagliara S
    mBio; 2021 Aug; 12(4):e0090921. PubMed ID: 34281389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific Enrichment and Proteomics Analysis of Escherichia coli Persisters from Rifampin Pretreatment.
    Sulaiman JE; Hao C; Lam H
    J Proteome Res; 2018 Nov; 17(11):3984-3996. PubMed ID: 30336045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disrupting folate metabolism reduces the capacity of bacteria in exponential growth to develop persisters to antibiotics.
    Morgan J; Smith M; Mc Auley MT; Enrique Salcedo-Sora J
    Microbiology (Reading); 2018 Nov; 164(11):1432-1445. PubMed ID: 30247120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large mutational target size for rapid emergence of bacterial persistence.
    Girgis HS; Harris K; Tavazoie S
    Proc Natl Acad Sci U S A; 2012 Jul; 109(31):12740-5. PubMed ID: 22802628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic tolerance: antibiotic enrichment of noninherited resistance in bacterial populations.
    Wiuff C; Zappala RM; Regoes RR; Garner KN; Baquero F; Levin BR
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1483-94. PubMed ID: 15793130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persister Heterogeneity Arising from a Single Metabolic Stress.
    Amato SM; Brynildsen MP
    Curr Biol; 2015 Aug; 25(16):2090-8. PubMed ID: 26255847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Throughput Screening of a Promoter Library Reveals New Persister Mechanisms in Escherichia Coli.
    Mohiuddin SG; Massahi A; Orman MA
    Microbiol Spectr; 2022 Feb; 10(1):e0225321. PubMed ID: 35196813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow-cytometry analysis reveals persister resuscitation characteristics.
    Mohiuddin SG; Kavousi P; Orman MA
    BMC Microbiol; 2020 Jul; 20(1):202. PubMed ID: 32640993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escherichia coli persister cells suppress translation by selectively disassembling and degrading their ribosomes.
    Cho J; Rogers J; Kearns M; Leslie M; Hartson SD; Wilson KS
    Mol Microbiol; 2015 Jan; 95(2):352-64. PubMed ID: 25425348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli.
    Hansen S; Lewis K; Vulić M
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2718-26. PubMed ID: 18519731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fast bacterial growth reduces antibiotic accumulation and efficacy.
    Łapińska U; Voliotis M; Lee KK; Campey A; Stone MRL; Tuck B; Phetsang W; Zhang B; Tsaneva-Atanasova K; Blaskovich MAT; Pagliara S
    Elife; 2022 Jun; 11():. PubMed ID: 35670099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergent antibiotic persistence in a spatially structured synthetic microbial mutualism.
    Xiong X; Othmer HG; Harcombe WR
    ISME J; 2024 Jan; 18(1):. PubMed ID: 38691424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of lag time underlies antibiotic tolerance in evolved bacterial populations.
    Fridman O; Goldberg A; Ronin I; Shoresh N; Balaban NQ
    Nature; 2014 Sep; 513(7518):418-21. PubMed ID: 25043002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell division in Escherichia coli cultures monitored at single cell resolution.
    Roostalu J; Jõers A; Luidalepp H; Kaldalu N; Tenson T
    BMC Microbiol; 2008 Apr; 8():68. PubMed ID: 18430255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 84.